← Back to screener

BIO-RAD LABORATORIES, INC. BIO

Rank #1358 · NYSE · $10.3B market cap
Audited by KPMG LLP, no going-concern flag in the latest filing.
Score
49.5
P/E
-16.2
P/B
1.07
ROE
-6.6%
Op. Margin
12.6%
Debt Ratio
29%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★★☆☆
Average

P/E -16.2x, P/B 1.07x. Ranks in the top 48% of the universe.

Profitability ★★☆☆☆
Average

ROE -6.6%. Ranks in the top 54% of the universe.

Safety ★★★★☆
Excellent

Debt ratio 29%. Ranks in the top 16% of the universe. Under 100% is generally considered a safe level.

Growth ★☆☆☆☆
Weak

Revenue decline of 4.7% year over year. Ranks in the top 75% of the universe.

Safety is the relative strength · Growth is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011–$0.2B$0.1B$1.5B–99
2012–$0.3B$0.2B$1.7B–78
2013–$0.3B$0.2B$2.0B–71
2014–$0.3B$0.2B$2.2B–55
2015–$0.2B$0.1B$2.2B–53
2016–$0.1B$0.1B$2.2B–56
2017–$0.2B$0.1B$2.2B–58
2018$2.1B$0.1B$0.0B$2.5B2.754
2019$2.2B$0.1B$0.1B$2.6B5.562
2020$2.3B$-0.1B$0.4B$2.9B-4.577
2021$2.3B$0.2B$1.8B$4.0B9.977
2022$2.5B$0.4B$3.8B$5.8B16.671
2023$2.9B$0.5B$4.3B$9.9B17.139
2024$2.8B$0.5B$-3.6B$13.7B17.226
2025$2.7B$0.3B$-0.6B$9.6B12.629

← See the full screener